Moloney Securities Asset Management’s Fresenius Medical Care FMS Stock Holding History

Moloney Securities Asset Management’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,071	Closed	-$206K	–	327
2019 Q1	$206K	Buy	+5,071	New	+$189K	0.07%	272
2018 Q4	–	Sell	-4,801	Closed	-$247K	–	295
2018 Q3	$247K	Sell	4,801 -74	-2%	-$3.7K	0.09%	236
2018 Q2	$245K	Sell	4,875 -171	-3%	-$8.67K	0.09%	239
2018 Q1	$258K	Buy	5,046 +116	+2%	+$6.19K	0.1%	230
2017 Q4	$259K	Sell	4,930 -223	-4%	-$11.1K	0.11%	207
2017 Q3	$252K	Hold	5,153	–	–	0.11%	210
2017 Q2	$249K	Buy	+5,153	New	+$237K	0.12%	196

Other funds holding FMS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JFL

Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return

Moloney Securities Asset Management's FMS Position: Q2 2019 in Review

Moloney Securities Asset Management sold out of Fresenius Medical Care (FMS) in Q2 2019, closing a stake of 5,071 shares — an estimated $206K sold.

Moloney Securities Asset Management first reported a position in FMS in Q2 2017 and held it in 7 quarters. The position peaked at $259K in Q4 2017. 175 funds tracked by Wall St. Rank hold FMS as of Q2 2019.

Moloney Securities Asset Management reported no remaining Fresenius Medical Care position as of Q2 2019 after selling out during the quarter.
Moloney Securities Asset Management sold 5,071 Fresenius Medical Care shares in Q2 2019, an estimated $206K.
Moloney Securities Asset Management first reported a position in Fresenius Medical Care in Q2 2017 and held it in 7 quarters.
Moloney Securities Asset Management's Fresenius Medical Care position peaked at $259K in Q4 2017.
175 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2019.

Based on Moloney Securities Asset Management's 13F filing for Q2 2019, filed 29 Jul 2019.